Effect of anticoagulant treatment measured by fibrinopeptide A (fpA) in patients with venous thrombo-embolism.
D000328:Adult; D000368:Aged; D000925:Anticoagulants; D004305:Dose-Response Relationship, Drug; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products; D005340:Fibrinogen / Q000097:blood*; D005344:Fibrinopeptide A / Q000097:blood*; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D010996:Pleural Effusion; D011655:Pulmonary Embolism / Q000188:drug therapy*; D012008:Recurrence; D013924:Thrombophlebitis / Q000188:drug therapy*; D013997:Time Factors
D000925:Anticoagulants; D005338:Fibrin Fibrinogen Degradation Products; D005344:Fibrinopeptide A; D005340:Fibrinogen; D006493:Heparin